# Tubulis

**Source:** https://www.startuphub.ai/startups/tubulis
**Profile type:** Startup

> Develops antibody-drug conjugates (ADCs) for targeted cancer therapy.

## About

Tubulis generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties, demonstrating durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models. Their lead programs, TUB-040 and TUB-030, are being evaluated in the clinic for high-need solid tumor indications. Tubulis aims to expand the therapeutic potential of ADCs for patients, partners, and through their pipeline.

## Key facts

- **Slug:** tubulis
- **Website:** https://gilead.com
- **Location:** Munich, Germany
- **Founded:** 2013-01-01
- **Employees:** 118
- **Operating status:** Active
- **Total funding:** $437M
- **Sectors / tags:** BiTech, MedTech, HealthTech, Drug Discovery, Oncology, Antibody-Drug Conjugates, Therapeutics
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/tubulis
  - Twitter: https://twitter.com/tubulis_gmbh

## Frequently asked

### What does Tubulis do?

Tubulis generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties, demonstrating durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models. Their lead programs, TUB-040 and TUB-030, are being evaluated in the clinic for high-need solid tumor indications. Tubulis aims to expand the therapeutic potential of ADCs for patients, partners, and through their pipeline.

### What is Tubulis's valuation?

StartupHub estimates Tubulis's effective valuation at $1.8B (range $1.1B to $2.6B, 19% confidence), based on comparable companies in the sector.

### How much funding has Tubulis raised?

Tubulis has raised a total of $437M in funding. The most recent round on record is Series C.

### Where is Tubulis headquartered?

Tubulis is headquartered in Munich, Germany.

### When was Tubulis founded?

Tubulis was founded in 2013.

### What industry does Tubulis operate in?

Tubulis operates in BiTech, MedTech, HealthTech, Drug Discovery, Oncology, Antibody-Drug Conjugates.

### How many employees does Tubulis have?

Tubulis has approximately 118 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Tubulis",
          "item": "https://www.startuphub.ai/startups/tubulis"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/tubulis#webpage",
      "url": "https://www.startuphub.ai/startups/tubulis",
      "name": "Tubulis - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Tubulis. Tubulis is a startup founded in 2013, operating in BiTech and MedTech. Develops antibody-drug conjugates (ADCs) for targeted cancer therapy. Headquartered in Munich, Germany. The company has approximately 118 employees.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/tubulis#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/tubulis#organization",
      "name": "Tubulis",
      "url": "https://gilead.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0fa4357f-08ed-4afb-a4a3-f358867880b4-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0fa4357f-08ed-4afb-a4a3-f358867880b4-square.webp",
      "description": "This is the official profile of Tubulis. Tubulis is a startup founded in 2013, operating in BiTech and MedTech. Develops antibody-drug conjugates (ADCs) for targeted cancer therapy. Headquartered in Munich, Germany. The company has approximately 118 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/tubulis",
        "https://twitter.com/tubulis_gmbh",
        "https://www.startuphub.ai/startups/tubulis"
      ],
      "foundingDate": "2013-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 118
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Munich",
        "addressCountry": "Germany"
      },
      "knowsAbout": [
        "BiTech",
        "MedTech",
        "HealthTech",
        "Drug Discovery",
        "Oncology",
        "Antibody-Drug Conjugates",
        "Therapeutics"
      ]
    }
  ]
}
```